Stock Ratings / Health Care / PCVX / forecast

LLY (72) JNJ (66) ABBV (71) UNH (70) ⌘ Pro Terminal →

Vaxcyte Inc. (PCVX) 12-Month Stock Forecast & Price Target Cone

$62.61 +1.87% NASDAQ • Public Delayed / 60s Snapshot

Vaxcyte Inc. (PCVX) carries a Roarable Rating of C- (Hold) with 60/100 RQD Confidence. The underlying business is intact, so current owners don’t need to panic-sell—but mixed big-money flow or rich pricing means new buyers can afford to wait for either a pullback or a B-or-higher upgrade.

ROARABLE C- • HOLD / WATCH Cap $9.85B

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

RQD QUANT TACHOMETERHOLD / WATCH • C-

JEV AI Jury Split (Battleground)

Cash

SEC

Whale

5-PILLAR SNOWFLAKE RADARRw D · Rk A-

Each axis scored 0–20

12M PRICE TARGET CONE+0.9% Base Target

WHALE OPTIONS TUG-OF-WAR:56% Call Buyers ($2.5M)

44% PutsMax Pain: $61.00

INTERACTIVE 12-MONTH POSITION SIMULATOR

Drag to Test Your PCVX Position Size: $10,000

Shares at $62.61: 159.7 sh

$1,000$10,000$25,000$50,000$100,000

12M Bear Case FloorTarget $49.27

$7,869

$-2,131 (-21.3%)

12M Consensus BaseTarget $63.17

$10,089

+$89 (+0.9%)

12M Bull Case BreakoutTarget $95.29

$15,220

+$5,220 (+52.2%)

Wall Street Analyst Breakdown & Historical Accuracy Audit (28 Desks)

Street Historical Accuracy: 64/100

● Strong Buy / Buy: 17● Hold: 9● Sell: 2

Wall Street Firm	Stance	12M Target	1Y Accuracy	Track Grade
Morgan StanleyInstitutional Equity Desk	HOLD	$66	74%	A
Goldman SachsSector Coverage Lead	BUY	$90	69%	B
JP MorganUS Large-Cap Research	HOLD	$56	58%	C

🔴 SUNDAY NIGHT PREP • 7:00 PM ETHosted Live by Perry Belcher & Guest Trading Systems Desk

Today's Top 3 RQD Strong Buys & Whale Accumulation Setups (Live PCVX Tape Review)

✓Live breakdown of today’s highest-scoring RQD Green-Light breakouts
✓1 urgent Red-Light accounting trap to cut from your watchlist immediately
✓Bring any ticker to live Q&A—we run it through the 5-Pillar RQD Radar on screen

RQD INSIDER CLUB UPGRADE$49/YEAR

Want Plain-English AI Custom Indicators, Daily Pro Trader Video Clips & SMS Crash Alerts?

🤖 Try AI Indicator Builder ($49/yr VIP) →$100K Arena

PCVX // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +8.37%▲ ASCENDING CHANNEL

2026-10-30O $62.59H $63.28L $61.02C $62.03VOL 1.71M

RES: $99.49SUP: $56.78SMA50: $61.60SMA200: $57.04

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

PCVX Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 PCVX Butterfly Map → + Track PCVX →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

16.8%/yr Implied 5Y Growth

vs. +19.8% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on PCVX today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for PCVX. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for PCVX today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

PCVX Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

What is PCVX's 12-month stock price target?

Vaxcyte Inc. (PCVX) carries a 12-month consensus base price target of $63.17 (+0.9% from $62.61), with a bull-case target of $95.29 and a bear-case floor of $49.27.